Johnson & Johnson: Cordis Corp. is our only medical device dog

June 4, 2010 by MassDevice staff

Johnson & Johnson gives an in-depth look at its medical device operations, revealing that its Cordis Corp. stents operation is the only lagging performer in its stable of seven medical device and diagnostics segments.

JNJ logo

Johnson & Johnson (NYSE:JNJ) provided investors and analysts with a glimpse into its medical device operation, which it called the world's largest.

Over the past two years, according to the presentation, the division posted $1.8 billion in operational sales growth (excluding special items such as acquisitions or legal expenses). The segment's total sales during the first quarter were $6.2 billion.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.